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Abstract
Objectives: To evaluate the efficacy of transurethral incision of the prostate (TUIP) compared to transurethral
resection of the prostate (TURP) in patients with small benign prostate adenoma, based on long-term
follow-up.
Patients and methods: We prospectively randomized 86 men with bladder outlet obstruction symptoms
caused by a prostate less than 30 g to undergo TUIP or TURP. The following preoperative parameters were
evaluated: prostate weight, international prostate symptom score (IPSS), voided volume, maximum flow
rate (Qmax) and post-void residual volume (PVR). Postoperatively the patients were followed up for 48
months and the following data were collected: morbidity, operative time, catheterization period, hospital
stay, Qmax, IPSS, voided volume, PVR and reoperation rate.
Results: A total of 80 of the 86 patients completed the study: 40 patients in each group. The mean age
of patients in group I (TURP) and group II (TUIP) was 63.6 and 66.2 years, respectively. Preoperative
parameters in both groups showed no statistically significant differences with regard to uroflow parameters
and prostate weight. At 48 months follow-up the mean voided volume increased from 161 ml to 356 ml in
ml in group II, Q-max increased from 8.4 to 18.4 in group I and 8.4 to 16.6 in
m 19 to 5.8 in group I and from 19 to 6.3 in group II and PVR decreased from
from 109 ml to 21 ml in Group II (all differences statistically significant).group I and from 161 ml to 341
group II, the IPSS decreased fro
107 ml to 20 ml in Group I and∗ Corresponding author.
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Comparing groups I and II there were statistically significant differences with regard to mean operative time
(60.0 versus 20.6 min), duration of catheterization (3.2 versus 2.2 days), hospital stay (3.7 versus 2.6 days),
and the incidence of postoperative retrograde ejaculation (52.5% versus 22.5%) and erectile dysfunction
(20% versus 7.5%).
Conclusion: TUIP and TURP for small prostatic adenoma of less than 30 g are equally effective in providing
symptomatic improvement. TUIP is more advantageous with to side-effects, operative time, hospital stay
and the duration of catheterization.
© 2012 Production and hosting by Elsevier B.V. on behalf of Pan African Urological Surgeons’ Association.
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ND licntroduction
enign prostatic hyperplasia (BPH) is a chronic progressive disor-
er. One third of men older than 60 years will develop obstructive
ymptoms due to BPH, and approximately 25% of them will even-
ually require surgical intervention [1]. The aim of treating BPH is
o improve bothersome lower urinary tract symptoms (LUTS) and
ssociated quality of life, and to prevent or decrease complications.
reatment options range from self-monitoring for mild symptoms,
o drugs or even surgical intervention for moderate to severe symp-
oms [2]. Despite many recent innovations, transurethral resection
f the prostate (TURP) has been the benchmark therapy for BPH
nd it is still considered the reference standard of surgical treatment
3].
URP is not without problems: 13% of patients need blood trans-
usion, 80% have retrograde ejaculation, and 15% complain of
rectile dysfunction (ED). When looking at longer follow-up, 10%
f patients will need a repeat procedure within 5 years and up to 5%
ill develop bladder neck stenosis or urethral stricture [4].
ransurethral incision of the prostate (TUIP) is a simpler, more cost-
ffective and less invasive procedure than TURP. It is recommended
or patients in whom preservation of erectile function and antegrade
jaculation are important [4]. It has been suggested that at least
alf of the patients who undergo TURP could be treated effectively
ith TUIP, avoiding the complication of TURP [1,4]. Despite the
ncouraging results of TUIP, concerns remain regarding the duration
f its efficacy, prostate size limitations and the re-operation rate [5].
UIP is considered an under-utilized procedure in England – only
500 of these cases are performed annually, compared to 25,000
URPs [2].
he aim of this study was to evaluate TURP versus TUIP after long-
erm follow-up in men with small prostatic adenoma ≤ 30 g, with
egard to efficacy, cost-effectiveness, adverse effects and reoperation
ate.
atients and methods
etween January 2005 and December 2010, 86 men were selected
rom a large number of patients presenting to our urology depart-
ents with LUTS. The inclusion criteria were as follows: being
n the waiting list for surgical treatment of BPH, total prostatic
eight ≤ 30 g as measured with transrectal ultrasound (TRUS), and
he ability to give informed consent. The exclusion criteria were: sus-
Open access under CC BY-NC-ected prostate cancer (abnormal digital rectal examination (DRE),
r elevated prostate specific antigen – PSA), bladder pathology
including mass, stones or chronic cystitis), prominent median lobe
f the prostate or inability to comply with the follow-up schedule.
(
L
mll patients were assessed for surgical and anesthetic fitness by
linical and laboratory evaluation. This included urine analysis,
enal function tests, coagulation profile, liver enzymes, full blood
ount, PSA, chest X-ray and electrocardiogram. The international
rostate symptom score (IPSS) [6] was documented and uroflowme-
ry (voided volume, maximum flow rate, average flow rate) was
erformed. The post-void residual urine volume (PVR) was cal-
ulated using ultrasound and confirmed by small caliber Nelaton
atheter.
iagnostic cystoscopy was performed under spinal anesthesia prior
o surgical intervention: TURP in group I patients and TUIP in
roup II. TURP was performed according to the standard tech-
ique using a 26F resectoscope and resecting the adenoma from
he bladder neck to the verumontanum up to the level of the
rostatic capsule. TUIP was performed by making bilateral inci-
ions extending from the ureteric orifice to the verumontanum
p to the level of the perivesical fat. A Collin’s knife was
sed. After obtaining hemostasis, a 20F three-way transurethral
atheter was inserted and continuous bladder irrigation started
5].
he following data were collected on all patients: operative time,
erioperative morbidity, length of hospital stay and catheteriza-
ion time. Follow-up visits were scheduled for every 6 months.
t 48 months follow-up IPSS and uroflowmetry (voided volume,
aximum flow rate, average flow rate, and PVR) were assessed.
tatistical analysis was performed using the paired samples test and
hi-square test with cross-tabulation for connected and unconnected
ariables.
esults
f the 86 patients enrolled, 80 completed the study: 40 patients in
ach group. The mean weight of the prostate was 27.6 ± 2.4 g for
URP (group I) and 28.2 ± 2.1 g for TUIP (group II) measured by
RUS. There were no statistically significant differences between
he groups with regard to age, pre-operative IPSS, uroflowmetry
arameters and prostate weight (Table 1).
hen intraoperative and immediate postoperative variables were
ompared, statistically significant differences were found with
egard to operative time, blood transfusion rate, duration of catheter-
zation and length of hospital stay in favor of the TUIP group II
ense.Table 2).
ong-term follow-up at 48 months revealed significant improve-
ents in both groups (Table 3).
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Table 1 Preoperative variables.
Parameter Group Min Max Mean ± SD p-Value
Age (years) TURP 54 71 63.6 ± 4.2 0.288
TUIP 53 72 66.2 ± 6.1
IPSS TURP 15 26 19 ± 2 0.814
TUIP 16 25 19 ± 2
Voided volume (ml) TURP 136 186 161.6 ± 12.1 0.921
TUIP 141 185 161.2 ± 11.2
Average flow rate (ml/s) TURP 2.5 5.3 4.05 ± 0.7 0.303
TUIP 2.6 5.2 3.8 ± 0.6
Maximum flow rate (ml/s) TURP 7.5 9.9 8.4 ± 0.6 0.584
TUIP 7.5 9.5 8.4 ± 0.6
Post-void residual volume (ml) TURP 79 131 107.5 ± 18.4 0.797
TUIP 81 131 109.4 ± 18.1
IPSS, international prostate symptoms score.
Table 2 Intraoperative and immediate postoperative variables.
TURP TUIP p-Value
Operative time (min) 60.0 (±6.1) 20.6 (±3.1) 0.000
Blood transfusion – N (%) 2 (5%) 0 (0%) 0.163
Duration of catheterization (days) 3.2 (±0.3) 2.2 (±0.3) 0.000
Length of hospital stay (days) 3.7 (±0.3) 2.6 (±0.3) 0.000
Table 3 Long-term follow-up (48 months).
Parameter Group Pre-operative (mean ± SD) At 48 months (mean ± SD) p-Value
IPSS TURP 19 ± 2 5.8 ± 1.1 0.000
TUIP 19 ± 2 6.3 ± 1.2 0.000
Voided volume (ml) TURP 161.6 ± 12.1 356.1 ± 36.5 0.000
TUIP 161.2 ± 11.2 341.4 ± 36.2 0.000
Average flow rate (ml/s) TURP 4.1 ± 0.7 7.5 ± 1 0.000
TUIP 3.8 ± 0.6 7.1 ± 0.8 0.000
Maximum flow rate (ml/s) TURP 8.4 ± 0.6 18.4 ± 1 0.000
TUIP 8.4 ± 0.6 16.6 ± 0.8 0.000
Post void residual volume TURP 107.5 ± 18.4 20.6 ± 5.3 0.000
8.1
R
o
dTUIP 109.4 ± 1
At 48 months follow-up there were statistically significant differ-
ences between the two groups in IPSS and maximum flow rate, in
favor of the TURP group I (Table 4).Complication and reoperation rates at 48 months follow-up are
shown in Table 5. Retrograde ejaculation and ED were signifi-
cantly less common in the TUIP compared with the TURP group.
w
a
o
i
Table 4 Comparison between TURP and TUIP at 48 months.
Parameter Group
IPSS TURP
TUIP
Voided volume (ml) TURP
TUIP
Average flow rate (ml/s) TURP
TUIP
Maximum flow rate (ml/s) TURP
TUIP
Post void residual volume (ml) TURP
TUIP21.7 ± 5.3 0.000
e-operation was required in 4 patients who complained of severe
bstructive voiding symptoms. Two patients in the TURP group
eveloped bladder neck contracture and were subsequently treated
ith TUIP. Two patients in the TUIP group had obstructive prostate
denoma tissue and were treated with TURP. Urethral stricture
ccurred in one patient in each group and was managed with visual
nternal urethrotomy.
Mean (±SD) p-Value
5.8 ± 1.1 0.025
6.3 ± 1.2
356.1 (±36.5) 0.226
341.4 (±36.2)
7.5 ± 1 0.079
7.1 ± 0.8
18.4 ± 1 0.000
16.6 ± 0.8
20.6 (±5.3) 0.507
21.7 (±5.3)
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Table 5 Complications at 48 months follow-up (values are shown as number and percentage).
TURP TUIP p-Value
Retrograde ejaculation 21 (52.5%) 9 (22.5%) 0.000
Erectile dysfunction 8 (20%) 3 (7.5%) 0.036
Bladder neck contracture 2 (5%) 0 (0%) 0.160
Prostatic adenoma obstruction 0 (0%) 2 (5%) 0.160
Urethral stricture (n %) 1 (2.5%) 1 (2.5%) 1.000
Reoperation 3 (7.5%) 3 (7.5%) 1.00
• Visual internal urethrotomy 1 (2.5%) 1 (2.5%) 1.00
• TURP 0 (0%) 2 (5%) 0.160
• TUIP 2 (5%) 0 (0%) 0.160
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Riscussion
URP has for many years been the most common method of
emoving obstructive prostatic adenoma through the urethra [7].
nstruments have undergone major technological improvements,
esulting in decreased morbidity and mortality. However, TURP is
till a potentially dangerous intervention, especially in the hands of
he inexperienced endoscopist [8].
n this study, TUIP was effective in improving IPSS scores and
roflow parameters, as was TURP. This is in accordance with the
ndings by Yang et al. [1] in their review which included nine trials
omparing the effectivity of TUIP versus TURP in prostates less
han 30 g.
ur results were comparable to those in many published series with
egard to the degree of improvement in symptom score and uroflow
arameters [5,9–11]. Patient satisfaction in the TUIP group was
imilar to that of the TURP group.
here were statistically significant differences in IPSS and maxi-
um flow rate between the 2 groups at 48 months follow-up, with
he TURP group doing better than the TUIP group. Other authors
eported similar results [5,7,12,13].
n our study, as in other studies, TUIP was associated with reduced
perative time, less need for blood transfusion, shorter hospital
tay, decreased period of catheterization and a lower incidence of
etrograde ejaculation [5,9,10,14].
kocz and Prajsner [15] concluded that TUIP, which is a simple
rocedure with low morbidity, could replace TURP for patients
ith prostates less than 30 g. Similarly Lourenco and co-workers
n a recent systematic review found that TUIP gave improvements
imilar to TURP, but with a lower incidence of adverse events [2].
n our study, the reoperation rate of 7.5% in both groups was dif-
erent from that reported in the meta-analysis done by Lourenco
nd associates, who found that reoperation after TUIP was required
ore frequently than after TURP: 18.4% versus 7.2% [2]. This may
e due to differences in the follow-up period and the small number
f patients in our study.he follow-up period in our study was 48 months, which is longer
han in the studies of Yang et al. [1] (3–12 months) and Riehmann
t al. [7] (36 months). Similar to our data, reoperation was mostly
erformed within the first 24 months postoperatively.ee and associates [16] extensively studied bladder neck contracture
n their series: at follow-up of more than 36 months 9.7% of patients
ad bladder neck contracture after TUIP compared to 12.3% of
atients after TURP. This rate was reduced to 6% when TURP was
ccompanied by TUIP.
ther studies [14,17,18] concluded that bladder neck contracture
ccurred in approximately 8% of patients after resection of less
han 20 g of prostatic tissue, and seldom after TUIP. In our study,
he reoperation rate for obstruction was equal in both groups (7.5%),
hich is similar to the other studies [16–18]. Some authors [19–21]
id not report a significant reoperation rate after TUIP.
he underlying pathology of obstruction in our geographical area
s often related to schistosomiasis and fibrosis of the prostate. This
ay explain the similar rate of recurrence of obstruction after TUIP
ompared with TURP. TUIP is preferable in many of these patients
ho are young and wish to father more children.
onclusion
n our study, TUIP and TURP were equally effective in provid-
ng symptomatic improvement in prostates less than 30 g. TUIP
as associated with fewer adverse events, required less oper-
tive time, shorter hospital stay and a shorter catheterization
eriod.
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